$KVUE · Kenvue Inc. SEC Filings
Position Tracker tracks 4 SEC EDGAR filings for Kenvue Inc. ($KVUE) from October 30, 2026 through November 5, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 3 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$KVUE 8-K — Kenvue Inc.
The filing confirms the final steps of Kimberly-Clark's takeover of Kenvue, including debt retirement and NYSE delisting.
$KVUE 8-K — Kenvue Inc.
The closing finalizes one of the largest consumer-health M&A deals, combining Kenvue's iconic OTC and skin-health brands with Kimberly-Clark's personal-care portfolio under a si…
$KVUE 8-K — Kenvue Inc.
Kenvue's fourth straight quarter of organic growth and margin expansion validates its standalone strategy just as it prepares to merge with Kimberly-Clark, making this one of th…
$KVUE 10-Q — Kenvue Inc.
Kenvue's Q3 shows accelerating operating leverage (18.2% margin) and declining restructuring costs, but the pending Kimberly-Clark deal overshadows standalone results.